HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuo Ikeda Selected Research

Yasuo Ikeda Research Topics

Disease

25Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
12/2015 - 04/2002
23Hemorrhage
10/2021 - 05/2002
22Neoplasms (Cancer)
04/2018 - 07/2003
22Thrombosis (Thrombus)
04/2018 - 01/2002
22Multiple Myeloma
12/2014 - 04/2002
17Thrombocytopenia (Thrombopenia)
11/2015 - 05/2002
11BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2011 - 06/2002
10Stroke (Strokes)
02/2021 - 12/2006
9Ischemic Stroke
02/2021 - 12/2006
9Myocardial Infarction
01/2020 - 12/2004
9Infections
01/2019 - 01/2002
8Hypertension (High Blood Pressure)
01/2021 - 01/2004
8Leukemia
03/2007 - 01/2002
7Body Weight (Weight, Body)
01/2020 - 05/2002
7Acute Coronary Syndrome
01/2020 - 01/2009
7Diabetes Mellitus
04/2018 - 01/2004
6Autoimmune Diseases (Autoimmune Disease)
12/2015 - 08/2003
6Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2014 - 06/2002
6Venous Thrombosis (Deep-Vein Thrombosis)
05/2009 - 03/2002
5Aplastic Anemia (Anemia, Hypoplastic)
01/2014 - 02/2003
5Sepsis (Septicemia)
06/2011 - 04/2003
5Graft vs Host Disease (Graft-Versus-Host Disease)
01/2009 - 06/2002
5Hematologic Neoplasms (Hematological Malignancy)
12/2008 - 08/2002
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2008 - 06/2002
5Acute Promyelocytic Leukemia
03/2005 - 01/2002
4Cardiovascular Diseases (Cardiovascular Disease)
02/2020 - 05/2014
4Embolic Stroke
01/2020 - 04/2018
4Dyslipidemias (Dyslipidemia)
01/2019 - 03/2010
4Vascular System Injuries
04/2010 - 01/2004
4Chromosome Aberrations (Chromosome Abnormalities)
06/2008 - 02/2003
4Anemia
09/2005 - 04/2002
4Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
02/2005 - 04/2002
3Transient Ischemic Attack
01/2016 - 12/2006
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2014 - 12/2011
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2014 - 08/2002
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2010 - 09/2005
3Connective Tissue Diseases (Connective Tissue Disease)
01/2009 - 10/2004
3Heart Failure
01/2009 - 01/2003
3Dermatomyositis (Dermatopolymyositis)
01/2009 - 05/2005
3Stomatitis
12/2008 - 04/2005
3Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
03/2008 - 10/2005
3Eosinophilia
09/2007 - 09/2004
3Central Nervous System Diseases (CNS Diseases)
01/2007 - 10/2002
3Myeloid Leukemia (Leukemia, Myelocytic)
10/2006 - 07/2002
3Pneumonia (Pneumonitis)
01/2006 - 09/2004
3Cytopenia
09/2005 - 09/2003
3Leukopenia
09/2005 - 09/2004

Drug/Important Bio-Agent (IBA)

21Inosine Triphosphate (ITP)IBA
12/2015 - 05/2002
18AutoantibodiesIBA
12/2015 - 04/2002
15Clopidogrel (Plavix)FDA Link
02/2021 - 01/2008
14Prasugrel HydrochlorideFDA Link
02/2021 - 05/2012
13Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2020 - 01/2007
12Imatinib Mesylate (Gleevec)FDA Link
05/2011 - 08/2002
8Pharmaceutical PreparationsIBA
09/2015 - 04/2004
8Thalidomide (Thalomid)FDA Link
10/2012 - 09/2002
8AntibodiesIBA
09/2012 - 08/2002
8Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2008 - 01/2002
7von Willebrand FactorIBA
03/2011 - 01/2002
6Proteins (Proteins, Gene)FDA Link
04/2011 - 11/2003
6Thrombopoietin (c-mpl Ligand)IBA
10/2008 - 08/2002
5Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2021 - 01/2006
5EnzymesIBA
01/2014 - 03/2002
5Immunoglobulin G (IgG)IBA
04/2012 - 01/2003
5Messenger RNA (mRNA)IBA
06/2011 - 01/2002
5CollagenIBA
03/2011 - 12/2003
5Adrenal Cortex Hormones (Corticosteroids)IBA
01/2009 - 05/2002
5Cytarabine (Cytosar-U)FDA LinkGeneric
12/2008 - 01/2004
5Monoclonal AntibodiesIBA
12/2004 - 01/2003
4Fibrinogen (Factor I)FDA Link
09/2015 - 07/2007
4Liposomes (Liposome)IBA
09/2015 - 04/2010
4Hemostatics (Antihemorrhagics)IBA
01/2013 - 01/2008
4AntigensIBA
04/2012 - 08/2002
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2012 - 04/2002
4Anti-Bacterial Agents (Antibiotics)IBA
06/2011 - 09/2005
4NF-kappa B (NF-kB)IBA
11/2007 - 01/2005
4Tretinoin (Retinoic Acid)FDA LinkGeneric
03/2005 - 07/2002
4Platelet Membrane GlycoproteinsIBA
02/2005 - 01/2002
3Purinergic P2Y Receptor AntagonistsIBA
01/2020 - 05/2012
3N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA
04/2018 - 12/2014
3Rituximab (Mabthera)FDA Link
12/2015 - 09/2005
3Adenosine Diphosphate (ADP)IBA
09/2015 - 08/2013
3Intravenous Immunoglobulins (IVIG)FDA Link
01/2014 - 01/2008
3Glycoproteins (Glycoprotein)IBA
08/2013 - 01/2003
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2011 - 01/2006
3SteroidsIBA
01/2008 - 05/2002
3SultanIBA
11/2007 - 07/2004
3CaspasesIBA
11/2007 - 07/2002
3Dexamethasone (Maxidex)FDA LinkGeneric
04/2007 - 01/2003
3Reactive Oxygen Species (Oxygen Radicals)IBA
10/2006 - 10/2004
3PolyphenolsIBA
03/2006 - 03/2005

Therapy/Procedure

30Therapeutics
01/2020 - 01/2002
11Hematopoietic Stem Cell Transplantation
01/2014 - 04/2004
11Transplantation
01/2008 - 06/2002
10Drug Therapy (Chemotherapy)
05/2014 - 01/2002
8Percutaneous Coronary Intervention
01/2020 - 05/2012
8Stem Cell Transplantation
01/2009 - 01/2003
7Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2006 - 06/2002
5Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
11/2006 - 09/2005
3Platelet Transfusion (Blood Platelet Transfusions)
01/2019 - 05/2002
3Drug Tapering
11/2008 - 09/2002